Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OEM Trademarks On Reprocessed Single-Use Devices Acceptable, FDA Says

This article was originally published in The Gray Sheet

Executive Summary

FDA regulations do not require reprocessors to remove original equipment manufacturer (OEM) trademarks and references to OEMs from reprocessed devices, but the reprocessor must make clear that it, not the OEM, is the manufacturer of the reprocessed single-use device, FDA states in its Sept. 17 denial of a petition from the Association of Disposable Device Manufacturers.

You may also be interested in...



Stakeholders Argue Over Deadline For Marking Of Reprocessed Devices

Senators Michael Enzi (R-Wyo.) and Edward Kennedy (D-Mass.) say FDA is misinterpreting deadlines for recently enacted device marking provisions

Stakeholders Argue Over Deadline For Marking Of Reprocessed Devices

Senators Michael Enzi (R-Wyo.) and Edward Kennedy (D-Mass.) say FDA is misinterpreting deadlines for recently enacted device marking provisions

MDUFMA Branding Provision Reprieve To Be Explained In Upcoming Guidance

FDA will give manufacturers 18 months to implement branding provisions of the Medical Device User Fee & Modernization Act upon issuance of a final guidance explaining how firms may achieve compliance

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015471

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel